Michael B Streiff

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. doi request reprint Thromboprophylaxis in nonsurgical patients
    Michael B Streiff
    Division of Hematology, Department of Medicine and Associate Faculty, Armstrong Institute of Patient Safety and Quality Care, Johns Hopkins University School of Medicine, 1830 E MonumentSt, Ste 7300, Baltimore, MD 21205, USA
    Hematology Am Soc Hematol Educ Program 2012:631-7. 2012
  2. ncbi request reprint Long-term therapy of venous thromboembolism in cancer patients
    Michael B Streiff
    Division of Hematology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
    J Natl Compr Canc Netw 4:903-10. 2006
  3. ncbi request reprint Duration of vitamin K antagonist therapy for venous thromboembolism: a systematic review of the literature
    Michael B Streiff
    Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Am J Hematol 81:684-91. 2006
  4. doi request reprint Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement
    Michael B Streiff
    Department of Medicine and Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    Ann Pharmacother 44:733-6. 2010
  5. doi request reprint Diagnosis and initial treatment of venous thromboembolism in patients with cancer
    Michael B Streiff
    Johns Hopkins Anticoagulation Service and Outpatient Clinics, Special Coagulation Laboratory, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    J Clin Oncol 27:4889-94. 2009
  6. doi request reprint Anticoagulation in the management of venous thromboembolism in the cancer patient
    Michael B Streiff
    Departments of Medicine and Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, 1830 East Monument Street, Suite 7300, Baltimore, MD 21205, USA
    J Thromb Thrombolysis 31:282-94. 2011
  7. ncbi request reprint Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure
    Michael B Streiff
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Transfusion 42:18-26. 2002
  8. doi request reprint Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma
    Elliott R Haut
    The Armstrong Institute for Patient Safety Division of Acute Care Surgery, Departmen of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA
    Arch Surg 147:901-7. 2012
  9. ncbi request reprint Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity deep vein thrombosis
    Hyun S Kim
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Cardiovasc Intervent Radiol 29:1003-7. 2006
  10. ncbi request reprint Management of venous thromboembolism: a systematic review for a practice guideline
    Jodi B Segal
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Ann Intern Med 146:211-22. 2007

Detail Information

Publications54

  1. doi request reprint Thromboprophylaxis in nonsurgical patients
    Michael B Streiff
    Division of Hematology, Department of Medicine and Associate Faculty, Armstrong Institute of Patient Safety and Quality Care, Johns Hopkins University School of Medicine, 1830 E MonumentSt, Ste 7300, Baltimore, MD 21205, USA
    Hematology Am Soc Hematol Educ Program 2012:631-7. 2012
    ..VTE prophylaxis prescription and administration rates are suboptimal and warrant multidisciplinary performance improvement strategies...
  2. ncbi request reprint Long-term therapy of venous thromboembolism in cancer patients
    Michael B Streiff
    Division of Hematology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
    J Natl Compr Canc Netw 4:903-10. 2006
    ..Several new anticoagulants are being investigated that promise greater therapeutic choices and potentially better outcomes for cancer patients with VTE...
  3. ncbi request reprint Duration of vitamin K antagonist therapy for venous thromboembolism: a systematic review of the literature
    Michael B Streiff
    Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Am J Hematol 81:684-91. 2006
    ..The aim of this study was to evaluate the evidence on the optimal duration of vitamin K antagonist (VKA) therapy for venous thromboembolism (VTE)...
  4. doi request reprint Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement
    Michael B Streiff
    Department of Medicine and Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    Ann Pharmacother 44:733-6. 2010
    ..In this commentary, we review the potential unintended consequences of this proposal and offer alternatives that we believe will increase the efficiency and quality of anticoagulation management...
  5. doi request reprint Diagnosis and initial treatment of venous thromboembolism in patients with cancer
    Michael B Streiff
    Johns Hopkins Anticoagulation Service and Outpatient Clinics, Special Coagulation Laboratory, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    J Clin Oncol 27:4889-94. 2009
    ..Venous thromboembolism (VTE) is a common complication of cancer and its therapy. The purpose of this article is to review the diagnosis and initial treatment of VTE in the patient with cancer...
  6. doi request reprint Anticoagulation in the management of venous thromboembolism in the cancer patient
    Michael B Streiff
    Departments of Medicine and Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, 1830 East Monument Street, Suite 7300, Baltimore, MD 21205, USA
    J Thromb Thrombolysis 31:282-94. 2011
    ..Prospective validation of these studies and testing of current risk assessment strategies in oncology patients is warranted. Management of recurrent VTE and unsuspected VTE in the cancer patient are also reviewed...
  7. ncbi request reprint Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure
    Michael B Streiff
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Transfusion 42:18-26. 2002
    ..FV inhibitors are a largely preventable iatrogenic coagulopathy in which the frequency is increasing in clinical practice...
  8. doi request reprint Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma
    Elliott R Haut
    The Armstrong Institute for Patient Safety Division of Acute Care Surgery, Departmen of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA
    Arch Surg 147:901-7. 2012
    ....
  9. ncbi request reprint Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity deep vein thrombosis
    Hyun S Kim
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Cardiovasc Intervent Radiol 29:1003-7. 2006
    ..To compare the efficacy of catheter-directed thrombolysis (CDT) alone versus CDT with rheolytic percutaneous mechanical thrombectomy (PMT) for upper and lower extremity deep vein thrombosis (DVT)...
  10. ncbi request reprint Management of venous thromboembolism: a systematic review for a practice guideline
    Jodi B Segal
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Ann Intern Med 146:211-22. 2007
    ..New treatments are available for treatment of venous thromboembolism...
  11. doi request reprint Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients
    Hyun S Kim
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore MD 21287, USA
    J Vasc Surg 47:388-94. 2008
    ..The current study was conducted to demonstrate that catheter-directed thrombolysis for upper and lower extremity deep vein thrombosis is equally safe in patients with and without cancer...
  12. doi request reprint Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events
    Amer M Zeidan
    Division of Hematology, Department of Medicine, The Johns Hopkins University, Baltimore, Maryland 21205
    Am J Hematol 88:545-9. 2013
    ....
  13. ncbi request reprint Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs
    Jodi B Segal
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Med 115:298-308. 2003
    ..To summarize the evidence comparing the efficacy, safety, and costs of outpatient and inpatient treatment of venous thromboembolism...
  14. ncbi request reprint Usefulness of clinical prediction rules for the diagnosis of venous thromboembolism: a systematic review
    Leonardo J Tamariz
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Med 117:676-84. 2004
    ..To summarize the evidence on the predictive value of clinical prediction rules for the diagnosis of venous thromboembolism...
  15. ncbi request reprint Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes
    Hyun S Kim
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 545, Baltimore, MD 21287 4010, USA
    J Vasc Interv Radiol 17:1099-104. 2006
    ..To assess the clinical and economic benefits of catheter-directed thrombolysis (CDT) alone versus CDT with rheolytic percutaneous mechanical thrombectomy (PMT) for lower-extremity deep vein thrombosis (DVT)...
  16. pmc Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies
    Kenneth M Shermock
    Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland, United States of America
    PLoS ONE 8:e66311. 2013
    ..Intervention strategies that target all patients have been effective, but prohibitively resource-intensive. We aimed to identify efficient intervention strategies based on patterns of non-administration of ordered VTE prophylaxis...
  17. ncbi request reprint Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature review
    John Eng
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 N Wolfe St, Central Radiology Viewing Area, Rm 117, Baltimore, MD 21287, USA
    AJR Am J Roentgenol 183:1819-27. 2004
    ..We sought to summarize systematically the published evidence describing the accuracy of contrast-enhanced helical CT for diagnosing pulmonary embolism...
  18. doi request reprint Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance
    Clifford M Takemoto
    Department of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Clin Pathol 139:450-6. 2013
    ..In conclusion, factor II and VIII activity contributes to discordance between APTT and anti-Xa results. ETP measurements may provide an additional assessment of anticoagulation status...
  19. doi request reprint Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative
    Michael B Streiff
    Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    BMJ 344:e3935. 2012
    ..Risk-appropriate prophylaxis can prevent most VTE events, but only a small fraction of patients at risk receive this treatment...
  20. doi request reprint Comparative performance of two methods that assess the quality of international normalized ratio measures
    Kenneth M Shermock
    Center for Pharmaceutical Outcomes, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Clin Biochem 45:530-4. 2012
    ..Both methods predict when alternate INR measures lead to different clinical decisions. Our goal was to compare their performance characteristics...
  21. doi request reprint A comparison of clinical outcomes with retrievable and permanent inferior vena cava filters
    Hyun S Kim
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 4010, USA
    J Vasc Interv Radiol 19:393-9. 2008
    ..To compare the clinical effectiveness of retrievable and permanent inferior vena cava (IVC) filters...
  22. ncbi request reprint Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis
    David E Gerber
    Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Cancer 109:300-5. 2007
    ..Therefore, we conducted a retrospective review of postoperative meningioma patients receiving contemporary VTE prophylaxis and diagnostic methods to define the current incidence of and risk factors for symptomatic VTE in this population...
  23. ncbi request reprint Vena caval filters: a review for intensive care specialists
    Michael B Streiff
    Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Ross Research Building, Room 1025, 720 Rutland Avenue, Baltimore, MD 21205, USA
    J Intensive Care Med 18:59-79. 2003
    ..Until additional data are available, vena caval filters should generally be restricted to patients with VTE who cannot receive anticoagulation...
  24. ncbi request reprint Management of venous thromboembolism in patients with primary and metastatic brain tumors
    David E Gerber
    Departments of Oncology, Medicine, and Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Clin Oncol 24:1310-8. 2006
    ..When intracranial hemorrhage does occur, it is often due to overanticoagulation, requiring prompt anticoagulation reversal and neurosurgical consultation...
  25. doi request reprint Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins Hospital
    Kimberly L Carter
    The Johns Hopkins Hospital, 600 North Wolfe Street, Carnegie 180, Baltimore, MD 21287, USA
    J Thromb Thrombolysis 34:437-45. 2012
    ..Many patients fell into the "cautioned" category, which demonstrates the complexity associated with selecting candidates for these new agents...
  26. doi request reprint Nonadministration of thromboprophylaxis in hospitalized patients with HIV: A missed opportunity for prevention?
    Matthew J Newman
    Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland
    J Hosp Med 9:215-20. 2014
    ..Previous work at our institution has demonstrated that the proportion of doses administered varies between patients and locations...
  27. ncbi request reprint Catheter-directed thrombolysis of inferior vena cava thrombosis in a 13-day-old neonate and review of literature
    Jawad U Khan
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Cardiovasc Intervent Radiol 31:S153-60. 2008
    ..We also review the literature on CDT for treatment of IVC thrombosis in critically ill neonates and infants...
  28. pmc Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication
    Rakhi P Naik
    Department of Medicine, Division of Hematology, Johns Hopkins University, Baltimore, MD 21205, USA
    Am J Med 126:443-9. 2013
    ..The purpose of this study was to establish the prevalence and risk factors for venous thromboembolism in a large cohort of patients with sickle cell disease and determine the relationship between venous thromboembolism and mortality...
  29. pmc Case report: perioperative use of protein c concentrate for protein C deficiency in THA
    Savyasachi C Thakkar
    Department of Orthopaedic Surgery, The Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, A665, Baltimore, MD, 21224 2780, USA
    Clin Orthop Relat Res 468:1986-90. 2010
    ..Perioperative management of patients with heterozygous protein C deficiency is challenging because of the competing risks of bleeding and recurrent thrombosis...
  30. ncbi request reprint The role of vena caval filters in the management of venous thromboembolism
    Christine L Hann
    Division of Hematology, Department of Medicine, Johns Hopkins Medical Institution, Bunting Blaustein Cancer Research Building, 1650 Orleans Street, Room 346, Baltimore, MD 21231, USA
    Blood Rev 19:179-202. 2005
    ..In this review, we will discuss the currently available IVC filters, data on their efficacy and safety and our assessment of appropriate indications for their use...
  31. doi request reprint Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program
    Jessica C Wellman
    Ambulatory Care and Anticoagulation Management, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Am J Health Syst Pharm 68:934-9. 2011
    ..CONCLUSION. Case-based advanced training and implementation of an IAP in a tertiary care hospital increased pharmacists' involvement in the management of inpatients receiving anticoagulants...
  32. pmc Venous thromboembolism in patients with HIV/AIDS: a case-control study
    Aima A Ahonkhai
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 48:310-4. 2008
    ..We investigated the prevalence of established risk factors for VTE in this population and explored novel risk factors...
  33. ncbi request reprint Results of an academic promotion and career path survey of faculty at the Johns Hopkins University School of Medicine
    Patricia A Thomas
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Acad Med 79:258-64. 2004
    ..The authors sought to quantify the magnitude of this difference in career advancement and to explore the characteristics of faculty that might explain the difference...
  34. doi request reprint Inflammatory bowel disease-associated thromboembolism: a systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis
    James H Tabibian
    Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA
    Inflamm Bowel Dis 18:161-71. 2012
    ..We reviewed clinical outcomes with anticoagulation (AC) and CDT in IBD patients with TE...
  35. doi request reprint Heparin-induced thrombocytopenia screening and management in pediatric patients
    Clifford M Takemoto
    Division of Pediatric Hematology, The Johns Hopkins University, Baltimore, MD 21205, USA
    Hematology Am Soc Hematol Educ Program 2011:162-9. 2011
    ..In this chapter, diagnostic approaches and management strategies based on a synthesis of the available pediatric studies and adult literature on HIT are discussed...
  36. doi request reprint Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse
    Huichun Zhan
    Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Ross Research 1032, 720 Rutland Avenue, Baltimore, MD 21205, USA
    Transfusion 50:868-74. 2010
    ..We aimed to describe the clinical spectrum of TTP, to determine the valid endpoint for plasma exchange cessation, and to explore the risk factors for disease relapse...
  37. ncbi request reprint The NCCN guidelines on venous thromboembolism
    Michael B Streiff
    Anticoagulation Management, Service and Outpatient Clinic, Staff Physician, Johns Hopkins Comprehensive Hemophilia Treatment Center, and Assistant Professor of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
    Clin Adv Hematol Oncol 5:117-9. 2007
  38. ncbi request reprint Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis
    Hyun S Kim
    Division of Vascular and Interventional Radiology, Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 545, Baltimore, Maryland 21205, USA
    J Vasc Interv Radiol 16:1685-91. 2005
    ..To evaluate clinical outcomes after percutaneous treatment of superior mesenteric vein (SMV) thrombosis...
  39. doi request reprint Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center
    Martin A Bishop
    From the Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland Division of Hematology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    ASAIO J 60:193-8. 2014
    ..026). There was no difference in the rate per patient-year of bleeding (0.23 vs. 0.33, p = 0.55) or thrombotic events (0.12 vs. 0.13, p = 0.88). Pharmacist-managed INR PST is associated with an increased %TTR in patients with LVADs. ..
  40. doi request reprint Females with subclavian vein thrombosis may have an increased risk of hypercoagulability
    Kendall Likes
    Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    JAMA Surg 148:44-9. 2013
    ..The objective of this study was to determine the prevalence of hypercoagulability in patients undergoing first rib resection and scalenectomy presenting with SVT...
  41. doi request reprint Evidence-based venous thromboembolism prophylaxis is associated with a six-fold decrease in numbers of symptomatic venous thromboembolisms in rehabilitation inpatients
    R Samuel Mayer
    Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD 21208, USA
    PM R 3:1111-1115.e1. 2011
    ....
  42. ncbi request reprint Iatrogenic symptomatic chest wall hematoma after shoulder arthroplasty. A report of two cases
    Ekavit Keyurapan
    Division of Sports Medicine and Shoulder Surgery, The Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD 21224 2780, USA
    J Bone Joint Surg Am 88:1603-8. 2006
  43. doi request reprint Hematological manifestations of nephropathic cystinosis
    Ashkan Emadi
    Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231 1000, USA
    Acta Haematol 119:169-72. 2008
    ....
  44. doi request reprint Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know
    Rakhi P Naik
    Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
    J Thromb Thrombolysis 35:352-8. 2013
    ..SCD complications such as acute chest syndrome and pulmonary hypertension may also be related to VTE. Anticoagulation experts should be aware of these factors to help inform prophylaxis and treatment decisions...
  45. doi request reprint Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices
    Elliott R Haut
    Division of Acute Care Surgery, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Trauma 70:27-33; discussion 33-4. 2011
    ..We hypothesized that trauma surgeons have varying opinions regarding duplex ultrasound screening for DVT in asymptomatic trauma patients, which result in varying practice patterns...
  46. ncbi request reprint ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas
    Michael B Streiff
    Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Cancer 100:1717-23. 2004
    ..To investigate the pathogenesis of VTE and facilitate targeted prophylaxis strategies, the authors aimed to characterize VTE risk factors in these patients...
  47. doi request reprint A superior method to report clinically relevant quality information about the point-of-care INR device performance compared with the International Organization for Standardization guidelines
    Kenneth M Shermock
    Center for Pharmaceutical Outcomes, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Clin Chim Acta 411:1756-60. 2010
    ..A revised ISO guideline was recently published that recommended methods to assess the quality of point-of-care INR measures. We assessed the relative performance of the ISO methods and a method that we developed...
  48. ncbi request reprint The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns
    Michael B Streiff
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Blood 99:1144-9. 2002
    ..A significant minority of physicians undertreat erythrocytosis, and little consensus exists regarding the treatment of thrombocytosis...
  49. ncbi request reprint Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference
    John A Kaufman
    The Dotter Interventional Institute, Oregon Health and Science University, Portland, Oregon, USA
    Surg Obes Relat Dis 2:200-12. 2006
  50. doi request reprint Impact of an inpatient anticoagulation management service on clinical outcomes
    Paula J Biscup-Horn
    Anticoagulation Management Service, Department of Pharmacy, Allegheny General Hospital, Pittsburgh, PA, USA
    Ann Pharmacother 42:777-82. 2008
    ..The benefits of specialized anticoagulation management services (AMS) in the outpatient setting are well established; less evidence of benefit in the hospital setting is available...
  51. ncbi request reprint Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference
    John A Kaufman
    Dotter Interventional Institute, Oregon Health and Science University, Portland, 97239, USA
    J Vasc Interv Radiol 17:449-59. 2006
  52. ncbi request reprint Venous thromboembolic disease. Clinical practice guidelines in oncology
    Lawrence D Wagman
    City of Hope Cancer Center, USA
    J Natl Compr Canc Netw 4:838-69. 2006
  53. ncbi request reprint Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
    Jerry A Krishnan
    N Engl J Med 349:398-400; author reply 398-400. 2003
  54. doi request reprint The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention
    David E Gerber
    Division of Hematology Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA
    Blood 112:504-10. 2008
    ..2; 95% CI, 1.4-3.6). In HSCT patients, VTE is primarily catheter-related and 3-fold less common than clinically significant bleeding. These findings warrant consideration when selecting VTE prophylaxis in HSCT patients...